PMC:7417114 / 28387-28503 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T156","span":{"begin":33,"end":40},"obj":"Body_part"}],"attributes":[{"id":"A156","pred":"fma_id","subj":"T156","obj":"http://purl.org/sig/ont/fma/fma9603"}],"text":"Vandetanib (Caprelsa)\n(medullary thyroid carcinoma; EGFR, RET, VEGFR) ABL2, EGFR, GAK, RET, SRC\nKd ABL1 (270nM) (48)"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T37","span":{"begin":33,"end":40},"obj":"Body_part"}],"attributes":[{"id":"A37","pred":"uberon_id","subj":"T37","obj":"http://purl.obolibrary.org/obo/UBERON_0002046"}],"text":"Vandetanib (Caprelsa)\n(medullary thyroid carcinoma; EGFR, RET, VEGFR) ABL2, EGFR, GAK, RET, SRC\nKd ABL1 (270nM) (48)"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T309","span":{"begin":23,"end":50},"obj":"Disease"},{"id":"T310","span":{"begin":33,"end":50},"obj":"Disease"},{"id":"T311","span":{"begin":41,"end":50},"obj":"Disease"}],"attributes":[{"id":"A309","pred":"mondo_id","subj":"T309","obj":"http://purl.obolibrary.org/obo/MONDO_0015277"},{"id":"A310","pred":"mondo_id","subj":"T310","obj":"http://purl.obolibrary.org/obo/MONDO_0015075"},{"id":"A311","pred":"mondo_id","subj":"T311","obj":"http://purl.obolibrary.org/obo/MONDO_0004993"}],"text":"Vandetanib (Caprelsa)\n(medullary thyroid carcinoma; EGFR, RET, VEGFR) ABL2, EGFR, GAK, RET, SRC\nKd ABL1 (270nM) (48)"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T342","span":{"begin":70,"end":74},"obj":"http://purl.obolibrary.org/obo/CLO_0053407"},{"id":"T343","span":{"begin":82,"end":85},"obj":"http://purl.obolibrary.org/obo/CLO_0037126"},{"id":"T344","span":{"begin":92,"end":95},"obj":"http://purl.obolibrary.org/obo/CLO_0009132"},{"id":"T345","span":{"begin":113,"end":115},"obj":"http://purl.obolibrary.org/obo/CLO_0001382"}],"text":"Vandetanib (Caprelsa)\n(medullary thyroid carcinoma; EGFR, RET, VEGFR) ABL2, EGFR, GAK, RET, SRC\nKd ABL1 (270nM) (48)"}

{"project":"LitCovid-PubTator","denotations":[{"id":"933","span":{"begin":52,"end":56},"obj":"Gene"},{"id":"934","span":{"begin":58,"end":61},"obj":"Gene"},{"id":"935","span":{"begin":63,"end":68},"obj":"Gene"},{"id":"936","span":{"begin":70,"end":74},"obj":"Gene"},{"id":"937","span":{"begin":76,"end":80},"obj":"Gene"},{"id":"938","span":{"begin":82,"end":85},"obj":"Gene"},{"id":"939","span":{"begin":87,"end":90},"obj":"Gene"},{"id":"940","span":{"begin":99,"end":103},"obj":"Gene"}],"attributes":[{"id":"A933","pred":"tao:has_database_id","subj":"933","obj":"Gene:1956"},{"id":"A934","pred":"tao:has_database_id","subj":"934","obj":"Gene:5979"},{"id":"A935","pred":"tao:has_database_id","subj":"935","obj":"Gene:3791"},{"id":"A936","pred":"tao:has_database_id","subj":"936","obj":"Gene:27"},{"id":"A937","pred":"tao:has_database_id","subj":"937","obj":"Gene:1956"},{"id":"A938","pred":"tao:has_database_id","subj":"938","obj":"Gene:2580"},{"id":"A939","pred":"tao:has_database_id","subj":"939","obj":"Gene:5979"},{"id":"A940","pred":"tao:has_database_id","subj":"940","obj":"Gene:25"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Vandetanib (Caprelsa)\n(medullary thyroid carcinoma; EGFR, RET, VEGFR) ABL2, EGFR, GAK, RET, SRC\nKd ABL1 (270nM) (48)"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T69","span":{"begin":23,"end":50},"obj":"Phenotype"}],"attributes":[{"id":"A69","pred":"hp_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/HP_0002865"}],"text":"Vandetanib (Caprelsa)\n(medullary thyroid carcinoma; EGFR, RET, VEGFR) ABL2, EGFR, GAK, RET, SRC\nKd ABL1 (270nM) (48)"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T89","span":{"begin":52,"end":56},"obj":"http://purl.obolibrary.org/obo/GO_0005006"},{"id":"T90","span":{"begin":76,"end":80},"obj":"http://purl.obolibrary.org/obo/GO_0005006"}],"text":"Vandetanib (Caprelsa)\n(medullary thyroid carcinoma; EGFR, RET, VEGFR) ABL2, EGFR, GAK, RET, SRC\nKd ABL1 (270nM) (48)"}

{"project":"LitCovid-sentences","denotations":[{"id":"T207","span":{"begin":0,"end":21},"obj":"Sentence"},{"id":"T208","span":{"begin":22,"end":95},"obj":"Sentence"},{"id":"T209","span":{"begin":96,"end":116},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Vandetanib (Caprelsa)\n(medullary thyroid carcinoma; EGFR, RET, VEGFR) ABL2, EGFR, GAK, RET, SRC\nKd ABL1 (270nM) (48)"}

{"project":"2_test","denotations":[{"id":"32778962-18183025-84130638","span":{"begin":113,"end":115},"obj":"18183025"}],"text":"Vandetanib (Caprelsa)\n(medullary thyroid carcinoma; EGFR, RET, VEGFR) ABL2, EGFR, GAK, RET, SRC\nKd ABL1 (270nM) (48)"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T666","span":{"begin":23,"end":32},"obj":"UBERON:0000958"},{"id":"T667","span":{"begin":33,"end":40},"obj":"UBERON:0002046"},{"id":"T668","span":{"begin":70,"end":74},"obj":"PR:000003583"},{"id":"T669","span":{"begin":82,"end":85},"obj":"PR:000007805"},{"id":"T670","span":{"begin":99,"end":103},"obj":"PR:000003582"}],"text":"Vandetanib (Caprelsa)\n(medullary thyroid carcinoma; EGFR, RET, VEGFR) ABL2, EGFR, GAK, RET, SRC\nKd ABL1 (270nM) (48)"}